Other
Laryngeal Mask Airway
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Laryngeal Mask Airway is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
24
clinical trials
Completed21 · 88%
Unknown status2 · 8%
Not yet recruiting1 · 4%
Clinical Trials
Trial Activity
24 trials
90% Effective Dose of Tegileridine Combined With Propofol for Inhibiting Laryngeal Mask Airway Insertion Responses in Patients of Different Ages: A Biased-Coin Sequential Allocation Dose-Finding Study
Not yet recruiting·—·Approved·NCT07665151·108 enrolled
the Effective Bolus Dose of Remifentanil for Laryngeal Mask Airway (LMA) Insertion in Children
Completed·—·N/A·NCT01919203·50 enrolled
Different Dose of Esketamine Inhibiting Response to Laryngeal Mask Airway Insertion
Completed·—·Phase 1·NCT06370130·58 enrolled
Effect of Fentanyl on Coughing and Recovery After Anesthesia With an LMA Laryngeal Mask Airway)for Airway Management
Completed·—·Phase 4·NCT01368809·100 enrolled
Dexmedetomidine for Laryngeal Mask Airway Insertion
Completed·—·Phase 4·NCT01852539·22 enrolled
Remifentanil for the I-gel and Laryngeal Mask Airway Insertion
Completed·—·Phase 4·NCT02382354·41 enrolled
Optimal Effect-site Concentration of Remifentanil for Inhibiting Response to Laryngeal Mask Airway (LMA) Removal
Completed·—·N/A·NCT01915108·128 enrolled
Dosing Study of Remifentanil for Smooth Removal of the Laryngeal Mask Airway (LMA)
Completed·—·Phase 4·NCT01931683·27 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)